This could readily explain why biochemically-distinct PrP assemblies from GSS patients with the P102L PrP mutation can transmit different phenotypes to experimental mice resulting in either a clinically silent PrP amyloidosis or a lethal spongiform encephalopathy (Piccardo et al., 2007; Barron et al., 2016; Barron, 2017). This evidence concerns the gene PRNP and prion disease.